| Patients Using Wellness Peptides Have No Reliable Information About Whether They Are Safe or Effective, ECRI and ISMP Warn |
| Monday, May 11, 2026 04:06 PM |
| New joint white paper asserts commercial market for compounded peptide products has outpaced the clinical evidence; unless the product is explicitly FDA-approved, there is insufficient evidence of its safety or efficacy. Read more. |